Toripalimab for Local-regional Recurrent Nasopharyngeal Carcinoma
Clinical trial NCT04376866 · RECRUITING
Trial details
- NCT number
- NCT04376866
- Sponsor
- Cancer Hospital of Guangxi Medical University
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-28
- Primary completion
- 2023-04-01
- Enrollment
- 204
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.